HYPERPHOSPHATAEMIA

This adverse event was reported 2152 times

HYPERPHOSPHATAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AMMONIUM CHLORIDE 94 0.3760
1 FUTIBATINIB 36 0.1622
2 CHLORAMPHENICOL SODIUM SUCCINATE 5 0.1515
3 BISMUTH SUBGALLATE 6 0.1304
4 ASIAN GINSENG 48 0.1137
5 NATAMYCIN 43 0.1049
6 SODIUM CITRATE 116 0.0924
7 DEXTROSE AND SODIUM CHLORIDE 13 0.0778
8 DOBUTAMINE HYDROCHLORIDE 84 0.0648
9 PEMIGATINIB 54 0.0633
See all drugs enriched for association with HYPERPHOSPHATAEMIA

HYPERPHOSPHATAEMIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Polyene Antimicrobial [EPC] 43 0.1049
1 Osmotic Diuretic [EPC] 122 0.0233
2 Vitamin K [EPC] 173 0.0200
3 Bismuth [EPC] 63 0.0113
4 Vitamin D3 Analog [EPC] 219 0.0108
5 Parenteral Iron Replacement [EPC] 145 0.0106
6 Stimulant Laxative [EPC] 142 0.0099
7 Vesicular Monoamine Transporter 2 Inhibitor [EPC] 10 0.0081
8 Vitamin D2 Analog [EPC] 39 0.0055
9 CD22-directed Immunoconjugate [EPC] 14 0.0047
See all drug classes enriched for association with HYPERPHOSPHATAEMIA